Short Course Radiotherapy Followed by CAPOX and Carrilizumab and Bevacizumab or Cetuximab for the Initial Treatment of Unresectable Metastatic Rectal Cancer
Conditions
- Unresectable Metastatic Rectal Cancer
- CAPOX
- Combination of Radioimmunotherapy
Interventions
- DRUG: CAPOX+ Camrelizumab+ Cetuximab
- DRUG: CAPOX+ Camrelizumab+ Bevacizumab
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology